Market Place
Sourcing Support
Verismo`s Activation Of Celestrial-301 Trial At Cancer Institute
08 Oct 2024 //
PR NEWSWIRE
Verismo Therapeutics Announces Upcoming Presentation at SITC 2023
03 Nov 2023 //
PR NEWSWIRE
Verismo starts patient enrolment for STAR-101 Phase I trial
03 May 2023 //
CLINICAL TRIALS ARENA
Verismo Secures Fast Track Designation from the FDA for SynKIR-110
05 Apr 2023 //
PR NEWSWIRE
US FDA grants orphan drug status for Verismo’s mesothelioma therapy
29 Sep 2022 //
PHARMACEUTICAL-TECHNOLOGY
FDA grants IND clearance for Verismo’s cancer therapy trial
21 Sep 2022 //
CLINICALTRIALSARENA
Verismo Announces FDA Clearance of IND Application for SynKIR-110
20 Sep 2022 //
FIRSTWORLDPHARMA
Verismo Therapeutics Announces FDA Clearance of IND Application for SynKIR-110
20 Sep 2022 //
PRNEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.